-29. Apr. 20191 Min.Origenis, A new approach to small molecule drug discoveryApril 29, 2019 A multipart AI-based, drug discovery platform, optimizing compounds for specificity, efficacy, physiochemical properties,...
-26. Apr. 20197 Min.Origenis featured on the cover of Pharma Tech Outlook Drug Discovery and Development edition!
-25. Jan. 20192 Min.Origenis GmbH Announces Global License and Collaboration Agreement with Expansion Therapeutics . . .January 25, 2019 Origenis GmbH Announces Global License and Collaboration Agreement with Expansion Therapeutics for Novel Therapies...